REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2017

Jun 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2017-06-15

Reporting Person: Terifay Robert J (EVP Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-15	Common Stock	M	48750	$52.03	Acquired	72043	Direct
2017-06-15	Common Stock	F	5411	$468.69	Disposed	66632	Direct
2017-06-15	Common Stock	F	22192	$468.69	Disposed	44440	Direct
2017-06-16	Common Stock	S	21147	$468.19	Disposed	23293	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-15	Non-Qualified Stock Option (right to buy)	$52.03	M	48750	Disposed	2021-12-16	Common Stock (48750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1699	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.